A multicentre, randomised phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer-Reference-Cited by-同舟云学术

A multicentre, randomised phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer

Published:2004-09 Issue:9 Volume:15 Page:1358-1365
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Tabernero J.,Climent M.A.,Lluch A.,Albanell J.,Vermorken J.B.,Barnadas A.,Antón A.,Laurent C.,Mayordomo J.I.,Estaun N.,Losa I.,Guillem V.,Garcia-Conde J.,Tisaire J.L.,Baselga J.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/15/9/1358/19448345/mdh349.pdf

Reference31 articles.

1. Docetaxel: overview of an active drug for breast cancer;Crown;Oncologist,2001

2. Taxane/anthracycline combinations: setting a new standard in breast cancer?;Nabholtz;Oncologist,2001

3. The current status of docetaxel for metastatic breast cancer;Esteva;Oncology (Huntingt),2002

4. Weekly docetaxel in breast cancer: applying clinical data to patient therapy;Baselga;Oncologist,2001

5. Treatment of patients resistant to anthracycline therapy;Ravdin;Anticancer Drugs,1996

Cited by 139 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A prospective comparison study utilizing patient-reported outcomes of taxane-related peripheral neuropathy between nab-paclitaxel and standard paclitaxel in patients with breast cancer;Breast Cancer;2024-03-08

2. A prospective comparison study utilizing patient-reported outcomes of taxane-related peripheral neuropathy between nab-paclitaxel and standard paclitaxel in patients with breast cancer;2023-10-04

3. Commonly prescribed medications associated with alopecia;Journal of the American Academy of Dermatology;2023-06

4. Microtubule Inhibitors;Holland‐Frei Cancer Medicine;2023-02-20

5. The influence of docetaxel schedule on treatment tolerability and efficacy in patients with metastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials;BMC Cancer;2022-01-25